✦ LIBER ✦

Phase I and pharmacokinetic study of ecteinascldin-743 (ET-743) given as a one hour infusion every 21 days

✍ Scribed by Twelves, C.J.; Vermorken, J.; Bowman, A.; Simpson, A.; Smyth, J.; Höppener, F.; Beijnen, J.; Jimeno, J.; Hanauske, A.-R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I and pharmacokinetic study of Yon

✍ C. Twelves; K. Hoekman; A. Bowman; J.B. Vermorken; A. Anthoney; J. Smyth; C. van 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 279 KB

Phase I trial of taxol given as a 3-hour

✍ Kris, M.G.; O'Connell, J.P.; Gralla, R.J. 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Phase I clinical study of ecteinascidin-

✍ Taamma, A.; Cvilkovic, E.; Jimeno, J.; Gasparetto, M.; Meeley, K.; Vega, E.; Cam 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 404 KB

550 Phase I and pharmacokinetic (PK) stu

✍ S.Q. Chu; G. Schwartz; M. Beeram; A. Patniak; M. Mita; J. Jimeno; L. Lopez-Laraz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 273 KB

A phase I trial and pharmacokinetic stud

✍ Meredith K. Chuk; Alberta Aikin; Trish Whitcomb; Brigitte C. Widemann; Peter Zan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

A phase I and pharmacokinetic study of R

✍ Abigerges, D; Catimel, G; Klink Alakl, M; Bruno, R; Chabot, G; Ardiet, C; Nieman 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 143 KB